Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment

https://doi.org/10.1016/S0033-0620(03)00087-2Get rights and content

Section snippets

Cigarette smoking and cardiovascular diseases

As reviewed in detail by Burns,1 smoking causes 140,000 premature deaths from cardiovascular disease annually in the United States, representing about 30% of all smoking-related deaths. Cigarette smoking acts synergistically with other cardiovascular risk factors to increase cardiovascular morbidity and mortality. Thus, in some countries of the world where poorly controlled hypertension, diabetes, and hyperlipidemia may have a higher prevalence than in the United States, cardiovascular disease

Pathophysiology of cigarette smoking and cardiovascular disease

A number of articles from this symposium address mechanisms by which cigarette smoking may increase the risk of cardiovascular disease. In this section, I will try to synthesize and integrate data on various mechanisms.

Cigarette smoking and cardiovascular disease: implications for treatment

In this section I will discuss the implications of research on the pathophysiology of cigarette smoking-induced cardiovascular disease on the treatment of smokers with cardiovascular disease. First, I will summarize the implications of cigarette smoking for the treatment of cardiovascular disease, then I will discuss the implications of cardiovascular disease for the treatment of nicotine addiction. Finally, I will comment on the economic aspects of smoking cessation therapy in relation to

Conclusions

These 3 issues of Progress in Cardiovascular Diseases provide a comprehensive review of cigarette smoking and cardiovascular disease. The pathophysiology of smoking as a cause of cardiovascular disease is complex and is not fully understood. However, the available information provides important insight not only into smoking but also into general mechanisms of atherogenesis and acute cardiovascular events, and how chemical factors may contribute. Even if smoking disappears, the research

Acknowledgements

I wish to thank Kaye Welch and Marc Olmsted for editorial assistance.

First page preview

First page preview
Click to open first page preview

References (124)

  • R. Puranik et al.

    Smoking and endothelial function

    Prog Cardiovasc Dis

    (2003)
  • R.A. Robbins et al.

    Smoking cessation is associated with an increase in exhaled nitric oxide

    Chest

    (1997)
  • P. Nicod et al.

    Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease

    J Am Coll Cardiol

    (1984)
  • J.E. Quillen et al.

    Acute effect of cigarette smoking on the coronary circulationconstriction of epicardial and resistance vessels

    J Am Coll Cardiol

    (1993)
  • M.D. Winniford et al.

    Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin

    Am J Cardiol

    (1987)
  • A. Nitenberg et al.

    Acetylcholine-induced coronary vasoconstriction in young, heavy smokers with normal coronary arteriographic findings

    Am J Med

    (1993)
  • T. Neunteufl et al.

    Contribution of nicotine to acute endothelial dysfunction in long-term smokers

    J Am Coll Cardiol

    (2002)
  • A. Cucina et al.

    Nicotine regulates basic fibroblastic growth factor and transforming growth factor β1 production in endothelial cells

    Biochem Biophys Res Commun

    (1999)
  • M. Tuut et al.

    Smoking, other risk factors and fibrinogen levelsEvidence of effect modification

    Ann Epidemiol

    (2001)
  • M.R. Adams et al.

    Cigarette smoking is associated with increased human monocyte adhesion to endothelial cellsreversibility with oral L-arginine but not vitamin C

    J Am Coll Cardiol

    (1997)
  • T. Yong et al.

    Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse

    J Neuroimmunol

    (1997)
  • N.L. Benowitz et al.

    Nicotine effects on eicosanoid formation and hemostatic functioncomparison of transdermal nicotine and cigarette smoking

    J Am Coll Cardiol

    (1993)
  • D. Harats et al.

    Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages

    Atherosclerosis

    (1989)
  • V. Stefanovich et al.

    The effect of nicotine on dietary atherogenesis in rabbits

    Exp Molec Path

    (1969)
  • S.S. Allen et al.

    Cholesterol changes in smoking cessation using the transdermal nicotine system

    Prev Med

    (1994)
  • A.A. Voors et al.

    Smoking and cardiac events after venous coronary bypass surgerya 15-year follow-up study

    Circulation

    (1996)
  • L.E. Daly et al.

    Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction

    Br Med J

    (1983)
  • L. Metz et al.

    Implications of cigarette smoking for the management of patients with acute coronary syndromes

    Prog Cardiovasc Dis

    (2003)
  • C.A. Knight-Lozano et al.

    Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues

    Circulation

    (2002)
  • M. Valkonen et al.

    Passive smoking induces atherogenic changes in low-density lipoprotein

    Circulation

    (1998)
  • S.A. Glantz et al.

    Passive smoking and heart disease. Epidemiology, physiology, and biochemistry

    Circulation

    (1991)
  • A. Wennmalm et al.

    Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men

    Circulation

    (1991)
  • N.L. Benowitz et al.

    Nicotine absorption and cardiovascular effects with smokeless tobacco usecomparison with cigarettes and nicotine gum

    Clin Pharmacol Ther

    (1988)
  • H.C. Porchet et al.

    Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics

    J Clin Invest

    (1987)
  • N.L. Benowitz et al.

    Daily use of smokeless tobaccoSystemic effects

    Ann Int Med

    (1989)
  • P.G. Persson et al.

    Cigarette smoking, oral moist snuff use, and glucose intolerance

    J Intern Med

    (2000)
  • N.L. Benowitz et al.

    Circadian blood nicotine concentrations during cigarette smoking

    Clin Pharmacol Ther

    (1982)
  • N.L. Benowitz et al.

    Stable isotope studies of nicotine kinetics and bioavailability

    Clin Pharmacol Ther

    (1991)
  • H.C. Porchet et al.

    Pharmacodynamic model of toleranceApplication to nicotine

    J Pharmacol Exp Ther

    (1988)
  • N.L. Benowitz et al.

    Interindividual variability in the metabolism and cardiovascular effects of nicotine in man

    J Pharmacol Exp Ther

    (1982)
  • N.L. Benowitz et al.

    Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking

    Clin Pharmacol Ther

    (1984)
  • E.N. Allred et al.

    Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease

    N Engl J Med

    (1989)
  • P.M.A. Calverley et al.

    Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema

    Br Med J

    (1981)
  • D.S. Sheps et al.

    Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease

    Ann Int Med

    (1990)
  • D.A. DeBias et al.

    Effects of carbon monoxide inhalation on ventricular fibrillation

    Arch Environ Health

    (1976)
  • D.F. Church et al.

    Free-radical chemistry of cigarette smoke and its toxicological implications

    Environ Health Perspect

    (1985)
  • J.D. Morrow et al.

    Increase in circulating products of lipid peroxidation (F2 - isoprostanes) in smokers

    N Engl J Med

    (1995)
  • A. Penn et al.

    Arteriosclerotic plaque development is ‘promoted’ by polynuclear aromatic hydrocarbons

    Carcinogenesis

    (1988)
  • A. Penn et al.

    1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development

    Circulation

    (1996)
  • O.L. Woodman

    Coronary vascular responses to nicotine in the anaesthetized dog

    Naunyn Schmiedebergs Arch Pharmacol

    (1991)
  • Cited by (336)

    View all citing articles on Scopus

    Preparation of this manuscript supported in part by USPHS grants DA02277 and DA12393 from the National Institute on Drug Abuse and by the Flight Attendants Medical Research Institute.

    View full text